A growth-hormone-releasing factor analogue of twenty-nine building blocks, also known as Modified GRF (1-29). Easily confused with the closely related sermorelin.
Vial size
$43.20
5 mg / vial · $8.64 / mg
Quantity
Add 1 more for 3% off
Bundle & save
1 vial
$43.20
each
2 vials
$41.90
3% off
3+ vials
$41.04
5% off
Per-vial price shown. The discount applies automatically at checkout.
Purchase options
Verification
Every batch is identified by a lot number, and its third-party certificate is listed here by lot. Measured values are shown only when they are real and independently verifiable.
Third-party testing in progress
We are currently having this product independently tested by a third-party laboratory. Its certificate of analysis will be published here as soon as the results are available — please check back soon. For laboratory research use only.
CJC-1295 (No DAC) is a growth-hormone-releasing factor analogue of twenty-nine building blocks, also known as Modified GRF (1-29). The 'No DAC' in the name marks it apart from a second version that carries an added component.
It is offered as a single-lot reference material, characterized independently and published per lot.
The detail that matters most here is telling it apart from sermorelin, a very close relative that a quick database lookup will sometimes return in its place. The two differ by a single building block, so they are near-identical in size — which means a careful identity check, not a glance at the name, is what reliably separates them. That is exactly the sort of confusion a reference standard exists to settle.
For laboratory research use only. Not for human or veterinary use.
CJC-1295 (No DAC), also called Modified GRF (1-29), is a growth-hormone-releasing-factor analogue and GHRH-receptor agonist. It is catalogued in growth-hormone-axis research as a releasing-factor reference.
Independent peer-reviewed literature that references CJC-1295 (No DAC).
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Teichman SL et al.
J Clin Endocrinol Metab2006
View source for Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults (opens in a new tab)Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse
Alba M et al.
Am J Physiol Endocrinol Metab2006
View source for Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse (opens in a new tab)Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
Ionescu M et al.
J Clin Endocrinol Metab2006
View source for Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog (opens in a new tab)Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects
Sackmann-Sala L et al.
Growth Horm IGF Res2009
View source for Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects (opens in a new tab)Citations are provided for educational and scientific reference only. They describe independent published research and are not product claims — they do not represent the performance, purity, or intended use of any material offered for sale.
General handling guidance for laboratory research materials — always defer to the product label and the lot certificate of analysis.
Research use only
For laboratory research use only. Not for human or veterinary use.
No reviews yet
Reviews are published only from verified purchases, so none appear until orders ship.
Peptide
A short synthetic peptide corresponding to a tail-end fragment of human growth hormone, with one extra building block added at the front.
Peptide
A synthetic peptide of fifteen building blocks (a pentadecapeptide), based on a partial sequence of a protein first identified in gastric juice.
Peptide blend
A blend of two peptides — BPC-157 and TB-500 — supplied together. A mixture, not a single substance, with no identity of its own.
Peptide
A larger peptide of thirty-seven building blocks, in the amylin-analogue class, carrying a fatty-acid tail attached to its chain.